Myelodysplastic myeloproliferative diseases
| Myelodysplastic myeloproliferative diseases | |
| MeSH | D054437 |
|---|---|
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Myelodysplastic-myeloproliferative diseases are a category of hematological malignancies disorders created by the World Health Organization which have characteristics of both myelodysplastic and myeloproliferative conditions.
Resources
- http://www.meb.uni-bonn.de/cancer.gov/CDR0000334473.html
- http://www.cancer.org/docroot/CRI/content/CRI_2_4_1X_What_is_myelodysplastic_syndrome_65.asp
- http://www.cancer.gov/cancertopics/pdq/treatment/mds-mpd/Patient
References
WikiDoc Research Resources for Myelodysplastic myeloproliferative diseases | |
|---|---|
| Articles on Myelodysplastic myeloproliferative diseases | Most recent articles on Myelodysplastic myeloproliferative diseases • Most cited articles on Myelodysplastic myeloproliferative diseases • Review articles on Myelodysplastic myeloproliferative diseases • Articles on Myelodysplastic myeloproliferative diseases in N Eng J Med, Lancet, BMJ |
| Media (Slides, Video, Images, MP3) on Myelodysplastic myeloproliferative diseases | Powerpoint slides on Myelodysplastic myeloproliferative diseases • Images of Myelodysplastic myeloproliferative diseases • Photos of Myelodysplastic myeloproliferative diseases • Podcasts & MP3s on Myelodysplastic myeloproliferative diseases • Videos on Myelodysplastic myeloproliferative diseases |
| Evidence Based Medicine Regarding Myelodysplastic myeloproliferative diseases | AND (Cochrane Database Syst Rev[http://worldselectshop.com/?id=9361 Cochrane Collaboration on Myelodysplastic myeloproliferative diseases • Bandolier on Myelodysplastic myeloproliferative diseases • TRIP on Myelodysplastic myeloproliferative diseases |
| Cost Effectiveness of Myelodysplastic myeloproliferative diseases | AND (Cost effectiveness) |
| group5 = Clinical Trials Involving Myelodysplastic myeloproliferative diseases | list5 = Ongoing Trials on Myelodysplastic myeloproliferative diseases at Clinical Trials.gov • Trial results on Myelodysplastic myeloproliferative diseases • Clinical Trials on Myelodysplastic myeloproliferative diseases at Google
| group6 = Guidelines / Policies / Government Resources (FDA/CDC) Regarding Myelodysplastic myeloproliferative diseases
| list6 = US National Guidelines Clearinghouse on Myelodysplastic myeloproliferative diseases • NICE Guidance on Myelodysplastic myeloproliferative diseases • NHS PRODIGY Guidance • FDA on Myelodysplastic myeloproliferative diseases • CDC on Myelodysplastic myeloproliferative diseases
| group7 = Textbook Information on Myelodysplastic myeloproliferative diseases
| list7 = Books and Textbook Information on Myelodysplastic myeloproliferative diseases
| group8 = Pharmacology Resources on Myelodysplastic myeloproliferative diseases
| list8 =
AND (Dose)}} Dosing of Myelodysplastic myeloproliferative diseases • AND (drug interactions)}} Drug interactions with Myelodysplastic myeloproliferative diseases • AND (side effects)}} Side effects of Myelodysplastic myeloproliferative diseases • AND (Allergy)}} Allergic reactions to Myelodysplastic myeloproliferative diseases • AND (overdose)}} Overdose information on Myelodysplastic myeloproliferative diseases • AND (carcinogenicity)}} Carcinogenicity information on Myelodysplastic myeloproliferative diseases • AND (pregnancy)}} Myelodysplastic myeloproliferative diseases in pregnancy • AND (pharmacokinetics)}} Pharmacokinetics of Myelodysplastic myeloproliferative diseases •
| group9 = Genetics, Pharmacogenomics, and Proteinomics of Myelodysplastic myeloproliferative diseases
| list9 =
AND (pharmacogenomics)}} Genetics of Myelodysplastic myeloproliferative diseases • AND (pharmacogenomics)}} Pharmacogenomics of Myelodysplastic myeloproliferative diseases • AND (proteomics)}} Proteomics of Myelodysplastic myeloproliferative diseases
| group10 = Newstories on Myelodysplastic myeloproliferative diseases
| list10 = Myelodysplastic myeloproliferative diseases in the news • Be alerted to news on Myelodysplastic myeloproliferative diseases • News trends on Myelodysplastic myeloproliferative diseases</small>
| group11 = Commentary on Myelodysplastic myeloproliferative diseases
| list11 =
Blogs on Myelodysplastic myeloproliferative diseases
| group12 = Patient Resources on Myelodysplastic myeloproliferative diseases | list12 = Patient resources on Myelodysplastic myeloproliferative diseases • Discussion groups on Myelodysplastic myeloproliferative diseases • Patient Handouts on Myelodysplastic myeloproliferative diseases • Directions to Hospitals Treating Myelodysplastic myeloproliferative diseases • Risk calculators and risk factors for Myelodysplastic myeloproliferative diseases
| group13 = Healthcare Provider Resources on Myelodysplastic myeloproliferative diseases
| list13 =
Symptoms of Myelodysplastic myeloproliferative diseases • Causes & Risk Factors for Myelodysplastic myeloproliferative diseases • Diagnostic studies for Myelodysplastic myeloproliferative diseases • Treatment of Myelodysplastic myeloproliferative diseases
| group14 = Continuing Medical Education (CME) Programs on Myelodysplastic myeloproliferative diseases | list14 = CME Programs on Myelodysplastic myeloproliferative diseases
| group15 = International Resources on Myelodysplastic myeloproliferative diseases | list15 = Myelodysplastic myeloproliferative diseases en Espanol • Myelodysplastic myeloproliferative diseases en Francais
| group16 = Business Resources on Myelodysplastic myeloproliferative diseases | list16 = Myelodysplastic myeloproliferative diseases in the Marketplace • Patents on Myelodysplastic myeloproliferative diseases
| group17 = Informatics Resources on Myelodysplastic myeloproliferative diseases | list17 = List of terms related to Myelodysplastic myeloproliferative diseases
}}
Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs
Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link HereThere is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
